SK Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Sell
303
-8
-3% -$8.17K 0.08% 60
2026
Q1
$288K Buy
311
+3
+1% +$3.04K 0.08% 65
2025
Q4
$315K Sell
308
-23
-7% -$22K 0.09% 63
2025
Q3
$283K Buy
331
+26
+9% +$19.3K 0.11% 70
2025
Q2
$240K Buy
305
+6
+2% +$4.66K 0.1% 70
2025
Q1
$244K Buy
299
+1
+0.3% +$832 0.13% 63
2024
Q4
$230K Hold
298
0.12% 61
2024
Q3
$234K Buy
+298
New +$268K 0.12% 61

Other funds holding LLY

SK Wealth Management's LLY Position: Q2 2026 in Review

SK Wealth Management reduced its Eli Lilly (LLY) stake by 2.6% in Q2 2026, selling an estimated $8.17K and leaving 303 shares worth $374K. The position accounts for 0.08% of the portfolio, ranked #60.

SK Wealth Management first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SK Wealth Management held 303 shares of Eli Lilly worth $374K as of Q2 2026.
  • SK Wealth Management sold 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.08% of SK Wealth Management's portfolio in Q2 2026, its #60 holding.
  • SK Wealth Management first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SK Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.